Trial Profile
Retrospective analysis of the efficacy and effects of liraglutide and sitagliptin in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2014
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Jan 2014 New trial record
- 06 Nov 2013 Results presented at the 16th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.